{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:30Z","timestamp":1789635750421,"version":"4.0.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Open Project Program of Jiangsu Key Laboratory of Zoonosis","award":["R2505"],"award-info":[{"award-number":["R2505"]}]},{"name":"Yangzhou Key Discipline Cultivation Program","award":["No.YZYXZDXK-010"],"award-info":[{"award-number":["No.YZYXZDXK-010"]}]},{"name":"Yangzhou Science and Technology Project","award":["SSF2025000070"],"award-info":[{"award-number":["SSF2025000070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02083-3","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:04:10Z","timestamp":1779987850000},"page":"3711-3733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SPP1 in Immunosuppressive Signaling in Lung Adenocarcinoma: Bulk and Single-Cell Transcriptomic Analysis"],"prefix":"10.1007","volume":"84","author":[{"given":"Lijun","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiantao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2083_CR1","doi-asserted-by":"crossref","unstructured":"Noguchi, M., et al. (June 1995). Small Adenocarcinoma of the Lung. Histologic Characteristics and Prognosis. Cancer (Vol. 75, pp. 2844\u20132852). Portico. 1210.1002\/1097-0142(19950615)75:12","DOI":"10.1002\/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#"},{"key":"2083_CR2","doi-asserted-by":"publisher","unstructured":"Gridelli, C. (2015). May. Non-Small-Cell Lung Cancer. Nature Reviews Disease Primers, vol. 1, no. 1, Crossref. https:\/\/doi.org\/10.1038\/nrdp.2015.9","DOI":"10.1038\/nrdp.2015.9"},{"key":"2083_CR3","doi-asserted-by":"crossref","unstructured":"Natarajan, S. R. (July 2022). MARK2\/4 Promotes Warburg Effect and Cell Growth in Non-Small Cell Lung Carcinoma through the AMPK\u03b11\/MTOR\/HIF-1\u03b1 Signaling Pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (Vol. 1869, p. 119242). Crossref. 710.1016\/j.bbamcr.2022.119242","DOI":"10.1016\/j.bbamcr.2022.119242"},{"key":"2083_CR4","doi-asserted-by":"publisher","unstructured":"Travis, W. D., & International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. (2011). Feb. Journal of Thoracic Oncology, vol. 6, no. 2, pp. 244\u2013285. Crossref. https:\/\/doi.org\/10.1097\/JTO.0b013e318206a221","DOI":"10.1097\/JTO.0b013e318206a221"},{"key":"2083_CR5","doi-asserted-by":"publisher","unstructured":"Shi, J. (2016). Dec. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study. PLOS Medicine, edited by Marc Ladanyi, vol. 13, no. 12, p. e1002162. Crossref. https:\/\/doi.org\/10.1371\/journal.pmed.1002162","DOI":"10.1371\/journal.pmed.1002162"},{"key":"2083_CR6","doi-asserted-by":"publisher","unstructured":"Cheng, T. Y. (2016). David, Oct. The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. Journal of Thoracic Oncology, vol. 11, no. 10, pp. 1653-71. Crossref. https:\/\/doi.org\/10.1016\/j.jtho.2016.05.021","DOI":"10.1016\/j.jtho.2016.05.021"},{"key":"2083_CR7","doi-asserted-by":"publisher","unstructured":"Rodak, O. (Sept. 2021). Current Landscape of Non-Small Cell Lung Cancer. Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy. Cancers (Vol. 13,18,13, no. 18, p. 4705). Crossref. https:\/\/doi.org\/10.3390\/cancers13184705","DOI":"10.3390\/cancers13184705"},{"key":"2083_CR8","doi-asserted-by":"publisher","unstructured":"Peters, S. (2018). Jan. PD-1 Blockade in Advanced NSCLC: A Focus on Pembrolizumab. Cancer Treatment Reviews, vol. 62, pp. 39\u201349. Crossref. https:\/\/doi.org\/10.1016\/j.ctrv.2017.10.002","DOI":"10.1016\/j.ctrv.2017.10.002"},{"key":"2083_CR9","doi-asserted-by":"publisher","unstructured":"Comprehensive Molecular Profiling of Lung Adenocarcinoma. Nature, vol. 511, no. 7511 (July 2014). pp. 543\u2009\u2013\u200950. Crossref. https:\/\/doi.org\/10.1038\/nature13385","DOI":"10.1038\/nature13385"},{"key":"2083_CR10","doi-asserted-by":"crossref","unstructured":"Santarpia, M., et al. (June 2020). Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1\/PD-L1 Antibodies. Cancers (Vol. 12, p. 1475). Crossref. 610.3390\/cancers12061475","DOI":"10.3390\/cancers12061475"},{"key":"2083_CR11","doi-asserted-by":"publisher","unstructured":"Mao, X. (2021). Oct. Crosstalk between Cancer-Associated Fibroblasts and Immune Cells in the Tumor Microenvironment: New Findings and Future Perspectives. Molecular Cancer, vol. 20, no. 1, Crossref. https:\/\/doi.org\/10.1186\/s12943-021-01428-1","DOI":"10.1186\/s12943-021-01428-1"},{"key":"2083_CR12","doi-asserted-by":"publisher","unstructured":"Pitt, J. M. (2016). Aug. Targeting the Tumor Microenvironment: Removing Obstruction to Anticancer Immune Responses and Immunotherapy. Annals of Oncology, vol. 27, no. 8, pp. 1482-92. Crossref. https:\/\/doi.org\/10.1093\/annonc\/mdw168","DOI":"10.1093\/annonc\/mdw168"},{"key":"2083_CR13","doi-asserted-by":"publisher","unstructured":"Zheng, S. (2018). Sept. A B7-CD28 Family Based Signature Demonstrates Significantly Different Prognoses and Tumor Immune Landscapes in Lung Adenocarcinoma. International Journal of Cancer, vol. 143, no. 10, pp. 2592\u2009\u2013\u2009601. Portico, Crossref. https:\/\/doi.org\/10.1002\/ijc.31764","DOI":"10.1002\/ijc.31764"},{"key":"2083_CR14","doi-asserted-by":"publisher","unstructured":"Marzagalli, M. (2019). Dec. Unraveling the Crosstalk between Melanoma and Immune Cells in the Tumor Microenvironment. Seminars in Cancer Biology, vol. 59, pp. 236\u2009\u2013\u200950. Crossref. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.002","DOI":"10.1016\/j.semcancer.2019.08.002"},{"key":"2083_CR15","doi-asserted-by":"publisher","unstructured":"Ohue, Y. (2016). Nov. Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells. Cancer Immunology Research, vol. 4, no. 12, pp. 1049-60. Crossref. https:\/\/doi.org\/10.1158\/2326-6066.cir-15-0266","DOI":"10.1158\/2326-6066.cir-15-0266"},{"key":"2083_CR16","doi-asserted-by":"publisher","unstructured":"Bussard, K. M. (2016). Aug. Tumor-Associated Stromal Cells as Key Contributors to the Tumor Microenvironment. Breast Cancer Research, vol. 18, no. 1, Crossref. https:\/\/doi.org\/10.1186\/s13058-016-0740-2","DOI":"10.1186\/s13058-016-0740-2"},{"key":"2083_CR17","doi-asserted-by":"publisher","unstructured":"Liu, X. (Nov. 2017). The Prognostic Landscape of Tumor-Infiltrating Immune Cell and Immunomodulators. Lung Cancer. Biomedicine & Pharmacotherapy (Vol. 95, pp. 55\u201361). Crossref. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.003","DOI":"10.1016\/j.biopha.2017.08.003"},{"key":"2083_CR18","doi-asserted-by":"publisher","unstructured":"Genova, C. (2022). Jan. Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade. Frontiers in Immunology, vol. 12, Crossref. https:\/\/doi.org\/10.3389\/fimmu.2021.799455","DOI":"10.3389\/fimmu.2021.799455"},{"key":"2083_CR19","doi-asserted-by":"publisher","unstructured":"Reck, M. (2016). Nov. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. The New England Journal of Medicine, vol. 375, no. 19, pp. 1823\u20131833. Crossref. https:\/\/doi.org\/10.1056\/NEJMoa1606774","DOI":"10.1056\/NEJMoa1606774"},{"key":"2083_CR20","doi-asserted-by":"crossref","unstructured":"Spella, M., & Stathopoulos, G. T. (Jan. 2021). Immune Resistance in Lung Adenocarcinoma. Cancers (Vol. 13, p. 384). Crossref. 310.3390\/cancers13030384","DOI":"10.3390\/cancers13030384"},{"key":"2083_CR21","doi-asserted-by":"publisher","unstructured":"Pan, D., & Jia, D. (2021). Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity. Frontiers in Molecular Biosciences, vol. 8, Oct. Crossref. https:\/\/doi.org\/10.3389\/fmolb.2021.757024","DOI":"10.3389\/fmolb.2021.757024"},{"key":"2083_CR22","doi-asserted-by":"publisher","unstructured":"Kim, N. (2020). May. Single-Cell RNA Sequencing Demonstrates the Molecular and Cellular Reprogramming of Metastatic Lung Adenocarcinoma. Nature Communications, vol. 11, no. 1, Crossref. https:\/\/doi.org\/10.1038\/s41467-020-16164-1","DOI":"10.1038\/s41467-020-16164-1"},{"key":"2083_CR23","doi-asserted-by":"publisher","unstructured":"Hu, J. (2023). Mar. Tumor Microenvironment Remodeling after Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer Revealed by Single-Cell RNA Sequencing. Genome Medicine, vol. 15, no. 1, Crossref. https:\/\/doi.org\/10.1186\/s13073-023-01164-9","DOI":"10.1186\/s13073-023-01164-9"},{"key":"2083_CR24","doi-asserted-by":"publisher","unstructured":"Yao, W. (2022). Dec. ScRNA-Seq and Bulk RNA-Seq Reveal the Characteristics of Ferroptosis and Establish a Risk Signature in Cholangiocarcinoma. Molecular Therapy - Oncolytics, vol. 27, pp. 48\u201360. Crossref. https:\/\/doi.org\/10.1016\/j.omto.2022.09.008","DOI":"10.1016\/j.omto.2022.09.008"},{"key":"2083_CR25","doi-asserted-by":"publisher","unstructured":"Zhang, D. (2022). Nov. Establishment of an Ovarian Cancer Omentum Metastasis-Related Prognostic Model by Integrated Analysis of ScRNA-Seq and Bulk RNA-Seq. Journal of Ovarian Research, vol. 15, no. 1, Crossref. https:\/\/doi.org\/10.1186\/s13048-022-01059-0","DOI":"10.1186\/s13048-022-01059-0"},{"key":"2083_CR26","doi-asserted-by":"publisher","unstructured":"Liu, X. (2022). Oct. Analysis on Heterogeneity of Hepatocellular Carcinoma Immune Cells and a Molecular Risk Model by Integration of ScRNA-Seq and Bulk RNA-Seq. Frontiers in Immunology, vol. 13, Crossref. https:\/\/doi.org\/10.3389\/fimmu.2022.1012303","DOI":"10.3389\/fimmu.2022.1012303"},{"key":"2083_CR27","doi-asserted-by":"crossref","unstructured":"Zhao, J., et al. (Dec. 2022). Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma. Biomolecules (Vol. 12, p. 1855). Crossref. 1210.3390\/biom12121855","DOI":"10.3390\/biom12121855"},{"key":"2083_CR28","doi-asserted-by":"publisher","unstructured":"AlMusawi, S. (2021). Feb. Understanding Cell-cell Communication and Signaling in the Colorectal Cancer Microenvironment. Clinical and Translational Medicine, vol. 11, no. 2, Portico, Crossref. https:\/\/doi.org\/10.1002\/ctm2.308","DOI":"10.1002\/ctm2.308"},{"key":"2083_CR29","doi-asserted-by":"crossref","unstructured":"Tkach, M., & Th\u00e9ry, C. (Mar. 2016). Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell (Vol. 164, pp. 1226\u20131232). Crossref. 610.1016\/j.cell.2016.01.043","DOI":"10.1016\/j.cell.2016.01.043"},{"key":"2083_CR30","doi-asserted-by":"publisher","unstructured":"Jabbari, N. (2020). Mar. Breast Cancer-derived Exosomes: Tumor Progression and Therapeutic Agents. Journal of Cellular Physiology, vol. 235, no. 10, pp. 6345-56. Portico, Crossref. https:\/\/doi.org\/10.1002\/jcp.29668","DOI":"10.1002\/jcp.29668"},{"key":"2083_CR31","doi-asserted-by":"publisher","unstructured":"Cervantes-Villagrana, R., Daniel (2020). June. Tumor-Induced Neurogenesis and Immune Evasion as Targets of Innovative Anti-Cancer Therapies. Signal Transduction and Targeted Therapy, vol. 5, no. 1, Crossref. https:\/\/doi.org\/10.1038\/s41392-020-0205-z","DOI":"10.1038\/s41392-020-0205-z"},{"key":"2083_CR32","doi-asserted-by":"publisher","unstructured":"Oldberg, A. (1986). Dec. Cloning and Sequence Analysis of Rat Bone Sialoprotein (Osteopontin) CDNA Reveals an Arg-Gly-Asp Cell-Binding Sequence. Proceedings of the National Academy of Sciences, vol. 83, no. 23, pp. 8819-23. Crossref. https:\/\/doi.org\/10.1073\/pnas.83.23.8819","DOI":"10.1073\/pnas.83.23.8819"},{"key":"2083_CR33","doi-asserted-by":"crossref","unstructured":"Ahmed, M. (July 2011). Osteopontin: A Potentially Important Therapeutic Target in Cancer. Expert Opinion on Therapeutic Targets (Vol. 15, pp. 1113\u20131126). Crossref. 910.1517\/14728222.2011.594438","DOI":"10.1517\/14728222.2011.594438"},{"key":"2083_CR34","doi-asserted-by":"publisher","unstructured":"Wei, R. (2017). Osteopontin -- a Promising Biomarker for Cancer Therapy. Journal of Cancer, vol. 8, no. 12, pp. 2173-83. Crossref. https:\/\/doi.org\/10.7150\/jca.20480","DOI":"10.7150\/jca.20480"},{"key":"2083_CR35","doi-asserted-by":"publisher","unstructured":"Hao, C. (2017). Apr. Human Osteopontin: Potential Clinical Applications in Cancer (Review). International Journal of Molecular Medicine, vol. 39, no. 6, pp. 1327-37. Crossref. https:\/\/doi.org\/10.3892\/ijmm.2017.2964","DOI":"10.3892\/ijmm.2017.2964"},{"key":"2083_CR36","doi-asserted-by":"publisher","unstructured":"ARAFAT, H. A., & OSTEOPONTIN GENE EXPRESSION AND IMMUNOLOCALIZATION IN THE RABBIT URINARY TRACT. Journal of Urology, vol. 167, no. 2 Part 1, Feb. 2002, pp. 746\u2009\u2013\u200952. Crossref. https:\/\/doi.org\/10.1016\/s0022-5347(01)69138-9","DOI":"10.1016\/s0022-5347(01)69138-9"},{"key":"2083_CR37","doi-asserted-by":"publisher","unstructured":"Wisniewski, T., et al. (May 2019). Osteopontin and Angiogenic Factors as New Biomarkers of Prostate Cancer. Urology Journal, 16(2), 134\u2013140. https:\/\/doi.org\/10.22037\/uj.v0i0.4282","DOI":"10.22037\/uj.v0i0.4282"},{"key":"2083_CR38","doi-asserted-by":"publisher","unstructured":"Pio, G. M. (2017). May. Soluble Bone-Derived Osteopontin Promotes Migration and Stem-like Behavior of Breast Cancer Cells. PLOS ONE, edited by Rajeev Samant, vol. 12, no. 5, p. e0177640. Crossref. https:\/\/doi.org\/10.1371\/journal.pone.0177640","DOI":"10.1371\/journal.pone.0177640"},{"key":"2083_CR39","doi-asserted-by":"publisher","unstructured":"Walaszek, K. (2018). Oct. Breast Cancer Risk in Premalignant Lesions: Osteopontin Splice Variants Indicate Prognosis. British Journal of Cancer, vol. 119, no. 10, pp. 1259-66. Crossref. https:\/\/doi.org\/10.1038\/s41416-018-0228-1","DOI":"10.1038\/s41416-018-0228-1"},{"key":"2083_CR40","doi-asserted-by":"publisher","unstructured":"Ostheimer, C. (2017). Oct. Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker Osteopontin. Frontiers in Immunology, vol. 8, Crossref. https:\/\/doi.org\/10.3389\/fimmu.2017.01305","DOI":"10.3389\/fimmu.2017.01305"},{"key":"2083_CR41","doi-asserted-by":"publisher","unstructured":"Yu, S. (2023). Apr. A Senescence-Based Prognostic Gene Signature for Colorectal Cancer and Identification of the Role of SPP1-Positive Macrophages in Tumor Senescence. Frontiers in Immunology, vol. 14, Crossref. https:\/\/doi.org\/10.3389\/fimmu.2023.1175490","DOI":"10.3389\/fimmu.2023.1175490"},{"key":"2083_CR42","doi-asserted-by":"publisher","unstructured":"Zhao, H. (2018). Mar. The Role of Osteopontin in the Progression of Solid Organ Tumour. Cell Death & Disease, vol. 9, no. 3, Crossref. https:\/\/doi.org\/10.1038\/s41419-018-0391-6","DOI":"10.1038\/s41419-018-0391-6"},{"key":"2083_CR43","doi-asserted-by":"publisher","unstructured":"Shevde, L. A., Rajeev, S., & Samant (July 2014). Role of Osteopontin in the Pathophysiology of Cancer. Matrix Biology (Vol. 37, pp. 131\u2013141). Crossref. https:\/\/doi.org\/10.1016\/j.matbio.2014.03.001","DOI":"10.1016\/j.matbio.2014.03.001"},{"key":"2083_CR44","doi-asserted-by":"publisher","unstructured":"Szklarczyk, D. (2016). Oct. The STRING Database in 2017: Quality-Controlled Protein-Protein Association Networks, Made Broadly Accessible. Nucleic Acids Research, vol. 45, no. D1, pp. D362-68. Crossref. https:\/\/doi.org\/10.1093\/nar\/gkw937","DOI":"10.1093\/nar\/gkw937"},{"key":"2083_CR45","doi-asserted-by":"crossref","unstructured":"Shannon, P., et al. (Nov. 2003). Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research (Vol. 13, pp. 2498\u20132504). Crossref. 1110.1101\/gr.1239303","DOI":"10.1101\/gr.1239303"},{"key":"2083_CR46","doi-asserted-by":"publisher","unstructured":"Jin, S. (2021). Feb. Inference and Analysis of Cell-Cell Communication Using CellChat. Nature Communications, vol. 12, no. 1, Crossref. https:\/\/doi.org\/10.1038\/s41467-021-21246-9","DOI":"10.1038\/s41467-021-21246-9"},{"key":"2083_CR47","doi-asserted-by":"publisher","unstructured":"Xiao, B. (2020). Dec. Identification and Verification of Immune-Related Gene Prognostic Signature Based on SsGSEA for Osteosarcoma. Frontiers in Oncology, vol. 10, Crossref. https:\/\/doi.org\/10.3389\/fonc.2020.607622","DOI":"10.3389\/fonc.2020.607622"},{"key":"2083_CR48","doi-asserted-by":"publisher","unstructured":"Liberzon, A. (2015). Dec. The Molecular Signatures Database Hallmark Gene Set Collection. Cell Systems, vol. 1, no. 6, pp. 417\u2009\u2013\u200925. Crossref. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004","DOI":"10.1016\/j.cels.2015.12.004"},{"key":"2083_CR49","doi-asserted-by":"publisher","unstructured":"Zappa, C., & Mousa, S. A. (2016). Non-Small Cell Lung Cancer: Current Treatment and Future Advances. Translational Lung Cancer Research, vol. 5, no. 3, June pp. 288\u2013300. Crossref. https:\/\/doi.org\/10.21037\/tlcr.2016.06.07","DOI":"10.21037\/tlcr.2016.06.07"},{"key":"2083_CR50","doi-asserted-by":"crossref","unstructured":"Ou, S. H., Ignatius, et al. (Aug. 2007). Prognostic Factors for Survival of Stage I Nonsmall Cell Lung Cancer Patients. Cancer (Vol. 110, pp. 1532\u20131541). Portico. 710.1002\/cncr.22938","DOI":"10.1002\/cncr.22938"},{"key":"2083_CR51","doi-asserted-by":"crossref","unstructured":"KONTOMANOLIS, E. M. M. A. N. U. E. L. N., et al. (Oct. 2020). Role of Oncogenes and Tumor-Suppressor Genes in Carcinogenesis: A Review. Anticancer Research (Vol. 40, pp. 6009\u20136015). Crossref. 1110.21873\/anticanres.14622","DOI":"10.21873\/anticanres.14622"},{"key":"2083_CR52","doi-asserted-by":"publisher","unstructured":"Li, F. (2022). July. Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma. Frontiers in Endocrinology, vol. 13, Crossref. https:\/\/doi.org\/10.3389\/fendo.2022.894754","DOI":"10.3389\/fendo.2022.894754"},{"key":"2083_CR53","doi-asserted-by":"publisher","unstructured":"Brahmer, J. (2015). July. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. The New England Journal of Medicine, vol. 373, no. 2, pp. 123\u2013135. Crossref. https:\/\/doi.org\/10.1056\/NEJMoa1504627","DOI":"10.1056\/NEJMoa1504627"},{"key":"2083_CR54","doi-asserted-by":"crossref","unstructured":"Herbst, R. S., et al. (Jan. 2018). The Biology and Management of Non-Small Cell Lung Cancer. Nature (Vol. 553, pp. 446\u2013454). Crossref. 768910.1038\/nature25183","DOI":"10.1038\/nature25183"},{"key":"2083_CR55","doi-asserted-by":"publisher","unstructured":"Altorki, N. K. (2019). Jan. The Lung Microenvironment: An Important Regulator of Tumour Growth and Metastasis. Nature Reviews Cancer, vol. 19, no. 1, pp. 9\u201331. Crossref. https:\/\/doi.org\/10.1038\/s41568-018-0081-9","DOI":"10.1038\/s41568-018-0081-9"},{"key":"2083_CR56","doi-asserted-by":"crossref","unstructured":"Meurette, O., & Mehlen, P. (Oct. 2018). Notch Signaling in the Tumor Microenvironment. Cancer Cell (Vol. 34, pp. 536\u2013548). Crossref. 410.1016\/j.ccell.2018.07.009","DOI":"10.1016\/j.ccell.2018.07.009"},{"key":"2083_CR57","doi-asserted-by":"publisher","unstructured":"Remark, R. (2015). Feb. The Non-Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient Outcome. American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 4, pp. 377\u2009\u2013\u200990. Crossref. https:\/\/doi.org\/10.1164\/rccm.201409-1671pp","DOI":"10.1164\/rccm.201409-1671pp"},{"key":"2083_CR58","doi-asserted-by":"publisher","unstructured":"Gordon, S. R. PD-1 Expression by Tumour-Associated Macrophages Inhibits Phagocytosis and Tumour Immunity. Nature, vol. 545, no. 7655, May 2017, pp. 495\u2009\u2013\u200999. Crossref. https:\/\/doi.org\/10.1038\/nature22396","DOI":"10.1038\/nature22396"},{"key":"2083_CR59","doi-asserted-by":"publisher","unstructured":"Huntington, N. D. The Cancer-Natural Killer Cell Immunity Cycle. Nature Reviews Cancer, vol. 20, no. 8, June 2020, pp. 437\u2009\u2013\u200954. Crossref. https:\/\/doi.org\/10.1038\/s41568-020-0272-z","DOI":"10.1038\/s41568-020-0272-z"},{"key":"2083_CR60","doi-asserted-by":"publisher","unstructured":"Zhang, Y. (2021). Mar. Single-cell RNA Sequencing in Cancer Research. Journal of Experimental & Clinical Cancer Research, vol. 40, no. 1, Crossref. https:\/\/doi.org\/10.1186\/s13046-021-01874-1","DOI":"10.1186\/s13046-021-01874-1"},{"key":"2083_CR61","doi-asserted-by":"crossref","unstructured":"Zhang, N., et al. (May 2022). UBE3A Deletion Enhances the Efficiency of Immunotherapy in Non-Small-Cell Lung Cancer. Bioengineered (Vol. 13, pp. 11577\u201311592). Crossref. 510.1080\/21655979.2022.2069328","DOI":"10.1080\/21655979.2022.2069328"},{"key":"2083_CR62","doi-asserted-by":"publisher","unstructured":"Anborgh, P. H. (2010). Aug. Role of the Metastasis-Promoting Protein Osteopontin in the Tumour Microenvironment. Journal of Cellular and Molecular Medicine, vol. 14, no. 8, pp. 2037\u20132044. Crossref. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01115.x","DOI":"10.1111\/j.1582-4934.2010.01115.x"},{"key":"2083_CR63","unstructured":"Fedarko, N. S. (2001). Dec. Elevated Serum Bone Sialoprotein and Osteopontin in Colon, Breast, Prostate, and Lung Cancer. Clinical Cancer Research, vol. 7, no. 12, pp. 4060-66."},{"key":"2083_CR64","doi-asserted-by":"publisher","unstructured":"Lin, F. (2010). Dec. Overexpression of Osteopontin in Hepatocellular Carcinoma and Its Relationships with Metastasis, Invasion of Tumor Cells. Molecular Biology Reports, vol. 38, no. 8, pp. 5205-10. Crossref. https:\/\/doi.org\/10.1007\/s11033-010-0671-4","DOI":"10.1007\/s11033-010-0671-4"},{"key":"2083_CR65","doi-asserted-by":"publisher","unstructured":"Hu, Z. Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non-Small Cell Lung Cancer. Clinical Cancer Research, vol. 11, no. 13, July 2005, pp. 4646-52. Crossref. https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-2013","DOI":"10.1158\/1078-0432.ccr-04-2013"},{"key":"2083_CR66","doi-asserted-by":"publisher","unstructured":"Xu, C. (2017). July. SPP1, Analyzed by Bioinformatics Methods, Promotes the Metastasis in Colorectal Cancer by Activating EMT Pathway. Biomedicine & Pharmacotherapy, vol. 91, pp. 1167-77. Crossref. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.056","DOI":"10.1016\/j.biopha.2017.05.056"},{"key":"2083_CR67","doi-asserted-by":"publisher","unstructured":"Chen, X., Crossref (Jan. 2019). doi:https:\/\/doi.org\/10.1007\/s00280-018-3759-5.","DOI":"10.1007\/s00280-018-3759-5"},{"key":"2083_CR68","doi-asserted-by":"crossref","unstructured":"Leveque, E., et al. (Mar. 2022). Phenotypic and Histological Distribution Analysis Identify Mast Cell Heterogeneity in Non-Small Cell Lung Cancer. Cancers (Vol. 14, p. 1394). Crossref. 610.3390\/cancers14061394","DOI":"10.3390\/cancers14061394"},{"key":"2083_CR69","doi-asserted-by":"publisher","unstructured":"Rawal, S. (2013). June. Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment. The Journal of Immunology, vol. 190, no. 12, pp. 6681-93. Crossref. https:\/\/doi.org\/10.4049\/jimmunol.1201363","DOI":"10.4049\/jimmunol.1201363"},{"key":"2083_CR70","doi-asserted-by":"publisher","unstructured":"Wang, H. (2017). Aug. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy. Trends in Cancer, vol. 3, no. 8, pp. 583\u2009\u2013\u200992. Crossref. https:\/\/doi.org\/10.1016\/j.trecan.2017.06.005","DOI":"10.1016\/j.trecan.2017.06.005"},{"key":"2083_CR71","doi-asserted-by":"publisher","unstructured":"Huppert, L. A. (2021). Aug. Tissue-Specific Tregs in Cancer Metastasis: Opportunities for Precision Immunotherapy. Cellular & Molecular Immunology, vol. 19, no. 1, pp. 33\u201345. Crossref. https:\/\/doi.org\/10.1038\/s41423-021-00742-4","DOI":"10.1038\/s41423-021-00742-4"},{"key":"2083_CR72","doi-asserted-by":"publisher","unstructured":"Takeuchi, Y., & Nishikawa, H. (2016). Roles of Regulatory T Cells in Cancer Immunity. International Immunology, vol. 28, no. 8, May pp. 401-09. Crossref. https:\/\/doi.org\/10.1093\/intimm\/dxw025","DOI":"10.1093\/intimm\/dxw025"},{"key":"2083_CR73","doi-asserted-by":"publisher","unstructured":"Manjili, M. H., & Butler, S. E. (2016). Role of Tregs in Cancer Dormancy or Recurrence. Immunological Investigations, vol. 45, no. 8, Sept. pp. 759\u2009\u2013\u200966. Crossref. https:\/\/doi.org\/10.1080\/08820139.2016.1194428","DOI":"10.1080\/08820139.2016.1194428"},{"key":"2083_CR74","doi-asserted-by":"publisher","unstructured":"Sarode, P., et al. (Jan. 2020). Epithelial Cell Plasticity Defines Heterogeneity in Lung Cancer. Cellular Signalling (Vol. 65, p. 109463). Crossref. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109463","DOI":"10.1016\/j.cellsig.2019.109463"},{"key":"2083_CR75","doi-asserted-by":"publisher","unstructured":"Milette, S. (2019). Mar. The Innate Immune Architecture of Lung Tumors and Its Implication in Disease Progression. The Journal of Pathology, vol. 247, no. 5, pp. 589\u2013605. Portico, Crossref. https:\/\/doi.org\/10.1002\/path.5241","DOI":"10.1002\/path.5241"},{"key":"2083_CR76","unstructured":"Patarca, R. (1993). Molecular and Cellular Basis of Genetic Resistance to Bacterial Infection: The Role of the Early T-Lymphocyte Activation-1\/Osteopontin Gene. Critical Reviews in Immunology, vol. 13, nos. 3\u20134, pp. 225\u2009\u2013\u200946."},{"key":"2083_CR77","doi-asserted-by":"publisher","unstructured":"Kolb, A. Osteopontin Influences the Invasiveness of Pancreatic Cancer Cells and Is Increased in Neoplastic and Inflammatory Conditions. Cancer Biology & Therapy, vol. 4, no. 7, July 2005, pp. 740\u2009\u2013\u200946. Crossref. https:\/\/doi.org\/10.4161\/cbt.4.7.1821","DOI":"10.4161\/cbt.4.7.1821"},{"key":"2083_CR78","doi-asserted-by":"crossref","unstructured":"Xiang, T., et al. (Apr. 2023). Important Oncogenic and Immunogenic Roles of SPP1 and CSF1 in Hepatocellular Carcinoma. Medical Oncology (Vol. 40). Crossref. 610.1007\/s12032-023-02024-7","DOI":"10.1007\/s12032-023-02024-7"},{"key":"2083_CR79","doi-asserted-by":"publisher","unstructured":"Wang, C. (2024). Apr. SPP1 Represents a Therapeutic Target That Promotes the Progression of Oesophageal Squamous Cell Carcinoma by Driving M2 Macrophage Infiltration. British Journal of Cancer, vol. 130, no. 11, pp. 1770-82. Crossref. https:\/\/doi.org\/10.1038\/s41416-024-02683-x","DOI":"10.1038\/s41416-024-02683-x"},{"key":"2083_CR80","doi-asserted-by":"publisher","unstructured":"Gao, C., et al. (Oct. 2020). SPP1 Promotes Chemoresistance and Stemness in Cancer via the FAK\/PI3K\/AKT Pathway. Frontiers in Oncology (Vol. 10, p. 574233). Crossref. https:\/\/doi.org\/10.3389\/fonc.2020.574233","DOI":"10.3389\/fonc.2020.574233"},{"key":"2083_CR81","doi-asserted-by":"publisher","unstructured":"Qi, J. (2022). Apr. Single-Cell and Spatial Analysis Reveal Interaction of FAP+ Fibroblasts and SPP1\u2009+\u2009Macrophages in Colorectal Cancer. Nature Communications, vol. 13, no. 1, Crossref. https:\/\/doi.org\/10.1038\/s41467-022-29366-6","DOI":"10.1038\/s41467-022-29366-6"},{"key":"2083_CR82","doi-asserted-by":"publisher","unstructured":"Li, S. (2024). Enhanced Bone Regeneration through Regulation of Mechanoresponsive FAK-ERK1\/2 Signaling by ZINC40099027 during Distraction Osteogenesis. International Journal of Medical Sciences, vol. 21, no. 1, pp. 137\u2009\u2013\u200950. Crossref. https:\/\/doi.org\/10.7150\/ijms.88298","DOI":"10.7150\/ijms.88298"},{"key":"2083_CR83","doi-asserted-by":"publisher","unstructured":"Patel, A. (July 2016). Novel Roles of Src in Cancer Cell Epithelial-to-Mesenchymal Transition. Vascular Permeability, Microinvasion and Metastasis. Life Sciences (Vol. 157, pp. 52\u201361). Crossref. https:\/\/doi.org\/10.1016\/j.lfs.2016.05.036","DOI":"10.1016\/j.lfs.2016.05.036"},{"key":"2083_CR84","doi-asserted-by":"publisher","unstructured":"Chen, T. (2023). Feb. Genistein Inhibits Proliferation and Metastasis in Human Cervical Cancer Cells through the Focal Adhesion Kinase Signaling Pathway: A Network Pharmacology-Based In Vitro Study in HeLa Cells. Molecules, vol. 28, no. 4, p. 1919. Crossref. https:\/\/doi.org\/10.3390\/molecules28041919","DOI":"10.3390\/molecules28041919"},{"key":"2083_CR85","doi-asserted-by":"crossref","unstructured":"Dong, Q., et al. (Mar. 2016). Osteopontin Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma through Regulating Vimentin. Oncotarget (Vol. 7, pp. 12997\u201313012). Crossref. 1110.18632\/oncotarget.7345","DOI":"10.18632\/oncotarget.7016"},{"key":"2083_CR86","doi-asserted-by":"publisher","unstructured":"Acloque, H. (2009). June. Epithelial-Mesenchymal Transitions: The Importance of Changing Cell State in Development and Disease. Journal of Clinical Investigation, vol. 119, no. 6, pp. 1438-49. Crossref. https:\/\/doi.org\/10.1172\/jci38019","DOI":"10.1172\/jci38019"},{"key":"2083_CR87","doi-asserted-by":"publisher","unstructured":"Thiery, J. P. Epithelial-Mesenchymal Transitions in Tumour Progression. Nature Reviews Cancer, vol. 2, no. 6, June 2002, pp. 442\u2009\u2013\u200954. Crossref. https:\/\/doi.org\/10.1038\/nrc822","DOI":"10.1038\/nrc822"},{"key":"2083_CR88","doi-asserted-by":"crossref","unstructured":"Thiery, J. P., et al. (Nov. 2009). Epithelial-Mesenchymal Transitions in Development and Disease. Cell (Vol. 139, pp. 871\u2013890). Crossref. 510.1016\/j.cell.2009.11.007","DOI":"10.1016\/j.cell.2009.11.007"},{"key":"2083_CR89","doi-asserted-by":"publisher","unstructured":"Kalluri, R. (2016). The Biology and Function of Fibroblasts in Cancer. Nature Reviews Cancer, vol. 16, no. 9, Aug. pp. 582\u2009\u2013\u200998. Crossref. https:\/\/doi.org\/10.1038\/nrc.2016.73","DOI":"10.1038\/nrc.2016.73"},{"key":"2083_CR90","doi-asserted-by":"publisher","unstructured":"Liu, Y., Zhang, D., Lin, R., Lian, Y., & Zhang, W. (2026). Jan. Age-Stratified Risk Analysis of Gastric Cancer: A Retrospective Hospital-Based Study of Helicobacter pylori, Smoking, and Dietary Patterns in South China Across Three Age Groups. Frontiers in Oncology, vol. 16, 22 article 1677546. https:\/\/doi.org\/10.3389\/fonc.2026.1677546","DOI":"10.3389\/fonc.2026.1677546"},{"key":"2083_CR91","doi-asserted-by":"crossref","unstructured":"Jiao, L. (2026). Bioinformatics Analysis of DLGAP5 as a Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration and Targeted Therapy. Discover Oncology, 17, article.","DOI":"10.1007\/s12672-025-04145-z"},{"key":"2083_CR92","doi-asserted-by":"crossref","unstructured":"Jiao, L. (2024). Bioinformatics Analysis of BTK Expression in Lung Adenocarcinoma: Implications for Immune Infiltration, Prognostic Biomarkers, and Therapeutic Targeting. 3 Biotech, vol. 14, article 215.","DOI":"10.1007\/s13205-024-04053-z"},{"key":"2083_CR93","doi-asserted-by":"publisher","unstructured":"George, B. (2014). Aug. Survival Analysis and Regression Models. Journal of Nuclear Cardiology, vol. 21, no. 4, pp. 686\u2009\u2013\u200994. Crossref. https:\/\/doi.org\/10.1007\/s12350-014-9908-2","DOI":"10.1007\/s12350-014-9908-2"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02083-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:15:26Z","timestamp":1789632926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02083-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":93,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02083-3","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"17 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study does not require approval from an ethics committee, because all analyses were conducted using publicly available datasets from GEO and TCGA. No human participants, identifiable personal data, or animal experiments were involved.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict if Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}